Efficacy of Transcatheter Arterial Chemoembolization Combined with Sirolimus for Treating Kasabach-Merritt Phenomenon in Infants, a Retrospective Study

Overview

Journal Ann Med

Publisher Informa Healthcare

Specialty General Medicine

Date 2023 Apr 11

PMID 37038342

Authors

Chuan-Gao Yin

Wei-Wei Qi

Song Wang

Deng Pan

Xiao-Li Chen

Shi-Yu Li

Affiliations

Soon will be listed here.

Abstract

Objective: This retrospective study aimed to observe the efficacy of transcatheter arterial chemoembolization (TACE) combined with sirolimus in the treatment of haemangioma combined with the Kasabach-Merritt phenomenon (KMP).

Methods: A total of 11 infants with KMP who were treated at our hospital from January 2016 to September 2021 were selected and treated with arteriosclerosis embolotherapy using a microsphere emulsion formed by bleomycin + ultra-fluid lipiodol + dexamethasone + contrast agent or bleomycin mixed microspheres as the embolising agent. The patients were administered sirolimus orally after TACE. The clinical efficacy and examination indicators before and after treatment were observed and compared.

Results: The 11 infants underwent TACE treatment by arteriosclerosis embolotherapy a total of 21 times; of these cases, 10 were cured, and 1 showed a moderate response. There were no cases of non-response or death. The platelet count rose from 10.0 (7.0, 18.0) x 10/L before TACE to 236.0 (188.0, 275.0) x 10/L six months after the first TACE, and the tumour size decreased from 49.0 (43.0, 111.7) cm before TACE to 7.0 (3.5, 17.0) cm six months after the first TACE. The differences were statistically significant (the Z values were -2.943 and -2.934, respectively, < 0.05).

Conclusion: The combination of TACE and sirolimus has significant efficacy on critical children with KMP.

References

Zhou S, Li H, Mao Y, Liu P, Zhang J . Successful treatment of Kasabach-Merritt syndrome with transarterial embolization and corticosteroids. J Pediatr Surg. 2013; 48(3):673-6. DOI: 10.1016/j.jpedsurg.2012.12.049. View

Peng S, Yang K, Xu Z, Chen S, Ji Y . Vincristine and sirolimus in the treatment of kaposiform haemangioendothelioma. J Paediatr Child Health. 2019; 55(9):1119-1124. DOI: 10.1111/jpc.14370. View

Labonnelie A, Soupre V, Maruani A, Cisternino S, Hadj-Rabia S, Boccara O . Management of sirolimus treatment for tumours associated with Kasabach-Merritt phenomenon. J Eur Acad Dermatol Venereol. 2022; 36(7):e586-e588. DOI: 10.1111/jdv.18077. View

Ying H, Qiao C, Yang X, Lin X . A Case Report of 2 Sirolimus-Related Deaths Among Infants With Kaposiform Hemangioendotheliomas. Pediatrics. 2018; 141(Suppl 5):S425-S429. DOI: 10.1542/peds.2016-2919. View

Wang P, Zhou W, Tao L, Zhao N, Chen X . Clinical analysis of Kasabach-Merritt syndrome in 17 neonates. BMC Pediatr. 2014; 14:146. PMC: 4088914. DOI: 10.1186/1471-2431-14-146. View

Liu X, Li J, Qu X, Yan W, Zhang L, Yang C . Treatment of kaposiform hemangioendothelioma and tufted angioma. Int J Cancer. 2016; 139(7):1658-66. DOI: 10.1002/ijc.30216. View

Kwok-Williams M, Perez Z, Squire R, Glaser A, Bew S, Taylor R . Radiotherapy for life-threatening mediastinal hemangioma with Kasabach-Merritt syndrome. Pediatr Blood Cancer. 2006; 49(5):739-44. DOI: 10.1002/pbc.20767. View

Ji Y, Chen S, Xiang B, Li K, Xu Z, Yao W . Sirolimus for the treatment of progressive kaposiform hemangioendothelioma: A multicenter retrospective study. Int J Cancer. 2017; 141(4):848-855. DOI: 10.1002/ijc.30775. View

Argenta L, Bishop E, Cho K, Andrews A, Coran A . Complete resolution of life-threatening hemangioma by embolization and corticosteroids. Plast Reconstr Surg. 1982; 70(6):739-44. DOI: 10.1097/00006534-198212000-00015. View

10.

Khant Z, Hirai T, Ikeda O, Furukoji E, Kadota Y, Azuma M . Successful transarterial embolization with cellulose porous beads for occipital haemangioma in an infant with Kasabach-Merritt syndrome. BJR Case Rep. 2018; 3(3):20170004. PMC: 6159188. DOI: 10.1259/bjrcr.20170004. View

11.

Yesudian P, Klafkowski J, Parslew R, Gould D, Lloyd D, Pizer B . Tufted angioma-associated Kasabach-Merritt syndrome treated with embolization and vincristine. Plast Reconstr Surg. 2007; 119(4):1392-1393. DOI: 10.1097/01.prs.0000255189.06739.07. View

12.

Wang Y, Kong L, Sun B, Cui J, Shen W . Sirolimus for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon in Two Infants. J Craniofac Surg. 2020; 31(4):1074-1077. DOI: 10.1097/SCS.0000000000006301. View

13.

Ryan C, Price V, John P, Mahant S, Baruchel S, Brandao L . Kasabach-Merritt phenomenon: a single centre experience. Eur J Haematol. 2009; 84(2):97-104. DOI: 10.1111/j.1600-0609.2009.01370.x. View

14.

Sakata N, Suenobu S, Okano M, Ueda S, Kimura M, Takemura T . Impact of sirolimus treatment for refractory kaposiform hemangioendothelioma with exacerbation of the disease 10 years after initial diagnosis. Rare Tumors. 2018; 10:2036361318776185. PMC: 5977423. DOI: 10.1177/2036361318776185. View

15.

Freixo C, Ferreira V, Martins J, Almeida R, Caldeira D, Rosa M . Efficacy and safety of sirolimus in the treatment of vascular anomalies: A systematic review. J Vasc Surg. 2019; 71(1):318-327. DOI: 10.1016/j.jvs.2019.06.217. View

16.

Wang Y, Wang S, Wang L, Bi S, Zhang J, Zha P . Transarterial Embolization in Neonatal Kasabach-Merritt Syndrome. Front Pediatr. 2021; 9:788120. PMC: 8671612. DOI: 10.3389/fped.2021.788120. View

17.

Jahnel J, Lackner H, Reiterer F, Urlesberger B, Urban C . Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: from vincristine to sirolimus. Klin Padiatr. 2012; 224(6):395-7. DOI: 10.1055/s-0032-1323823. View

18.

Garcia-Monaco R, Giachetti A, Peralta O, Napoli N, Lobos P, Gioseffi L . Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with embolization and vincristine in two newborns. J Vasc Interv Radiol. 2012; 23(3):417-22. DOI: 10.1016/j.jvir.2011.12.007. View

19.

ORegan G, Irvine A, Yao N, OMarcaigh A, Sheridan-Pereira M, Phelan E . Mediastinal and neck kaposiform hemangioendothelioma: report of three cases. Pediatr Dermatol. 2009; 26(3):331-7. DOI: 10.1111/j.1525-1470.2009.00913.x. View

20.

Cashell J, Smink G, Helm K, Xavier F . Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus. Pediatr Blood Cancer. 2018; 65(12):e27305. DOI: 10.1002/pbc.27305. View